title: Dipeptide gamma-d-Glu-d-Trp (thymodepressin) inhibits migration of CD34+ cells from the bone marrow into peripheral blood during tumor growth.
abstract: We studied the effect of dipeptide gamma-d-Glu-d-Trp (thymodepressin) on migration of CD34+ hemopoietic precursors and their direct adhesion to fibronectin in tumor-bearing mice on days 8, 11, 15, and 17 of tumor growth and on expression of CXCR-4 (CD184+) to SDF-1 and integrin beta1 (CD29+) by bone marrow cells. In tumor-bearing mice treated with gamma-d-Glu-d-Trp, the percent of CD34+ hemopoietic precursors in the peripheral blood considerably decreased throughout the observation period; the content of CD34+ hemopoietic precursors in the tumor tissue was 2-3-fold below the control against the background of increased content of CD34+ cells in the bone marrow. In animals treated with the peptide, the content of cells expressing CXCR-4 in the peripheral blood, bone marrow, and tumor tissue significantly decreased, while the percent of cells expressing integrin beta1 receptor (CD29+) in the bone marrow increased 2-fold, which was paralleled by an almost 2-fold increase in the percent of cells binding to fibronectin. We hypothesized that dipeptide gamma-d-Glu-d-Trp suppressed mobilization/migration of CD34+ hemopoietic precursor cells from the bone marrow to the peripheral blood of tumor-bearing mice.
authors.affiliation: Medical Radiological Research Center, Russian Academy of Medical Sciences, Obninsk, Russia. ovs45@mail.ru
authors.forename: O V
authors.initials: OV
authors.lastname: Semina
authors.forename: T N
authors.initials: TN
authors.lastname: Semenets
authors.forename: I A
authors.initials: IA
authors.lastname: Zamulaeva
authors.forename: E I
authors.initials: EI
authors.lastname: Selivanova
authors.forename: T P
authors.initials: TP
authors.lastname: Iljina
authors.forename: Ya V
authors.initials: YV
authors.lastname: Maliutina
authors.forename: D Yu
authors.initials: DY
authors.lastname: Semin
authors.forename: V I
authors.initials: VI
authors.lastname: Deigin
authors.forename: A S
authors.initials: AS
authors.lastname: Saenko
mesh_terms: D000818:Animals; D018952:Antigens, CD34 / Q000378:metabolism*; D001854:Bone Marrow Cells / Q000187:drug effects* / Q000502:physiology; D002465:Cell Movement / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009369:Neoplasms / Q000473:pathology / Q000503:physiopathology; D010455:Peptides / Q000494:pharmacology*
chemical_list: D018952:Antigens, CD34; D010455:Peptides; C449663:thymodepressin